Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID‐19 pneumonia: A pilot study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID‐19 pneumonia: A pilot study
Authors
Keywords
-
Journal
CELL PROLIFERATION
Volume 53, Issue 12, Pages -
Publisher
Wiley
Online
2020-11-18
DOI
10.1111/cpr.12947
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
- (2020) Yingxia Liu et al. Science China-Life Sciences
- MSC Based Therapies—New Perspectives for the Injured Lung
- (2020) Judith Behnke et al. Journal of Clinical Medicine
- Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series
- (2020) Anish R. Mitra et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
- (2020) Rong-Hui Du et al. EUROPEAN RESPIRATORY JOURNAL
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
- (2020) Giacomo Grasselli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage
- (2020) Jingyuan Liu et al. Journal of Translational Medicine
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19
- (2020) Vikram Sengupta et al. STEM CELLS AND DEVELOPMENT
- Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial
- (2018) Michael A Matthay et al. Lancet Respiratory Medicine
- The immunomodulatory function of mesenchymal stem cells: mode of action and pathways
- (2015) Antonio Uccelli et al. Annals of the New York Academy of Sciences
- Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial
- (2015) Jennifer G Wilson et al. Lancet Respiratory Medicine
- Targeting Macrophage Subsets for Infarct Repair
- (2014) Tamar Ben-Mordechai et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia
- (2012) Kristen A. Tropea et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started